Search research articles
Contact Us
Filters
Showing results (21-30 of 109) with videos related to
Page
of 11
Sort By:
Medicinal Research Reviews
|
August 9, 2020
Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era
Dunhui Li, Frank L Mastaglia, Sue Fletcher, et al.
The Journal of Gene Medicine
|
November 14, 2008
By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping
Chalermchai Mitrpant, Sue Fletcher, Patrick L Iversen, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities
Bal Hari Poudel, Sue Fletcher, Steve D Wilton, et al.
Human Mutation
|
June 24, 2008
Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping
Heidi R Madden, Sue Fletcher, Mark R Davis, et al.
Molecular Therapy. Nucleic Acids
|
June 4, 2026
Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression
Isabella Trew, Steve D Wilton, Jessica M Cale, et al.
Molecular Therapy. Nucleic Acids
|
March 20, 2014
Targeted exon skipping to correct exon duplications in the dystrophin gene
Kane L Greer, Hanns Lochmüller, Kevin Flanigan, et al.
International Journal of Molecular Sciences
|
October 21, 2020
Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in <i>COL7A1</i>
Kristin A Ham, May Thandar Aung-Htut, Sue Fletcher, et al.
International Journal of Molecular Sciences
|
November 6, 2019
Removal of the Polyglutamine Repeat of Ataxin-3 by Redirecting pre-mRNA Processing
Craig S McIntosh, May Thandar Aung-Htut, Sue Fletcher, et al.
Biomedicines
|
November 27, 2021
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
Craig S McIntosh, Dunhui Li, Steve D Wilton, et al.
Journal of Biomolecular Screening
|
November 1, 2012
A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation
Catherine Moorwood, Neha Soni, Gopal Patel, et al.
Page
of 11
Search research articles
Search
Showing results (21-30 of 109) with videos related to
Sort By:
Page
of 11
Medicinal Research Reviews
|
August 9, 2020
Progress in the molecular pathogenesis and nucleic acid therapeutics for Parkinson's disease in the precision medicine era
Dunhui Li, Frank L Mastaglia, Sue Fletcher, et al.
The Journal of Gene Medicine
|
November 14, 2008
By-passing the nonsense mutation in the 4 CV mouse model of muscular dystrophy by induced exon skipping
Chalermchai Mitrpant, Sue Fletcher, Patrick L Iversen, et al.
International Journal of Molecular Sciences
|
June 19, 2024
Limb Girdle Muscular Dystrophy Type 2B (LGMD2B): Diagnosis and Therapeutic Possibilities
Bal Hari Poudel, Sue Fletcher, Steve D Wilton, et al.
Human Mutation
|
June 24, 2008
Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping
Heidi R Madden, Sue Fletcher, Mark R Davis, et al.
Molecular Therapy. Nucleic Acids
|
June 4, 2026
Expanding the toolbox: Emerging antisense oligonucleotide mechanisms for modulating gene expression
Isabella Trew, Steve D Wilton, Jessica M Cale, et al.
Molecular Therapy. Nucleic Acids
|
March 20, 2014
Targeted exon skipping to correct exon duplications in the dystrophin gene
Kane L Greer, Hanns Lochmüller, Kevin Flanigan, et al.
International Journal of Molecular Sciences
|
October 21, 2020
Nonsequential Splicing Events Alter Antisense-Mediated Exon Skipping Outcome in <i>COL7A1</i>
Kristin A Ham, May Thandar Aung-Htut, Sue Fletcher, et al.
International Journal of Molecular Sciences
|
November 6, 2019
Removal of the Polyglutamine Repeat of Ataxin-3 by Redirecting pre-mRNA Processing
Craig S McIntosh, May Thandar Aung-Htut, Sue Fletcher, et al.
Biomedicines
|
November 27, 2021
Polyglutamine Ataxias: Our Current Molecular Understanding and What the Future Holds for Antisense Therapies
Craig S McIntosh, Dunhui Li, Steve D Wilton, et al.
Journal of Biomolecular Screening
|
November 1, 2012
A cell-based high-throughput screening assay for posttranscriptional utrophin upregulation
Catherine Moorwood, Neha Soni, Gopal Patel, et al.
Page
of 11